City Therapeutics, Inc.

expected

Oct 12, 2026

per news reports

status

Listed

proposed ticker

CTY

The expected listing date (Oct 12, 2026) comes from news reporting, not a regulatory filing — regulators publish a filing or approval date, not the day a company starts trading. See the source. It is replaced automatically if an official date is published.

Industry

Pharmaceutical Preparations

Headquarters

United States

Incorporated in

Underwriters (from filing)

Goldman Sachs & Co. LLC, Jefferies LLC, Stifel, Nicolaus & Company, Incorporated, Oppenheimer & Co. Inc

Overview

— AI-generated from the filing, see note below

Business overview

City Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing RNA interference (RNAi) therapeutics aimed at silencing disease-relevant proteins to provide benefits for patients with significant unmet medical needs. The company, founded in July 2023, is advancing multiple programs in areas such as thromboembolic diseases, Stargardt disease, and anemia of chronic disease. With a leadership team experienced in RNAi therapeutics, City Therapeutics aims to deliver one to two investigational new drug applications annually.

Revenue model

Not disclosed in the provided filing text.

Last FY net loss

$59M

Competitive strengths

Deep expertise in RNAi technology
Proven leadership team with extensive experience in RNAi
Strong pipeline addressing significant unmet medical needs

Risk factors

Limited operating history which may impact assessment of future viability
No products approved for commercial sale and no revenue generated
Significant ongoing losses and potential need for additional capital to fund operations and development
Uncertainty regarding the completion and success of clinical trials

Use of proceeds

Not disclosed in the provided filing text.

This summary is generated automatically from the company's own filing and may contain errors or omissions. It is a reading aid, not a substitute for the filing itself, and it is not advice.

IPO details

The expected date is Oct 12, 2026. The proposed ticker is CTY. Underwriters on the deal include Goldman Sachs & Co. LLC, Jefferies LLC, Stifel, Nicolaus & Company, Incorporated, Oppenheimer & Co. Inc. City Therapeutics, Inc. is headquartered in United States and incorporated in DE. It is classified under Pharmaceutical Preparations.

Estimated post-listing dates

The dates below are calculated from widely-used industry conventions, not from this offering's own disclosed terms — DiscoverIPO does not have a structured source for the actual figures. Treat them as reference points, not confirmed dates.

Lock-up expiry (estimated): Apr 10, 2027, based on a customary 180-day lock-up period. The actual length is set in the underwriting agreement — typically 90 to 180 days — and this offering's real terms may differ.
Quiet period end (estimated): Nov 6, 2026, based on the customary 25-day quiet period convention following a US listing.

Related IPO lists

Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with City Therapeutics, Inc..

Biotech IPOs United States IPOs Goldman Sachs & Co. LLC IPOs Jefferies LLC IPOs Stifel, Nicolaus & Company, Incorporated IPOs

Embed this company

Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.

Iframe — WordPress / Ghost / Notion / Webflow

<iframe src="https://www.discoveripo.com/embed/city-therapeutics" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="City Therapeutics, Inc. — DiscoverIPO"></iframe>

Dark by default. For a light background, use https://www.discoveripo.com/embed/city-therapeutics?theme=light as the src instead.

Share image — Substack, email, anywhere

https://www.discoveripo.com/ipo/city-therapeutics/opengraph-image

Attribution text

City Therapeutics, Inc. IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/city-therapeutics?utm_source=embed&utm_medium=text&utm_campaign=city-therapeutics

Track this IPO

Get emailed when City Therapeutics, Inc.'s terms, price, or expected date change — no weekly noise, just this company.

Frequently asked questions

When is City Therapeutics, Inc. expected to go public?

City Therapeutics, Inc. is expected to list on Oct 12, 2026.

What is City Therapeutics, Inc.'s ticker symbol?

City Therapeutics, Inc.'s proposed ticker is CTY.

Where this data comes from

Registration statement filed with the U.S. Securities and Exchange Commission. Retrieved Oct 9, 2026.

View the original filing on SEC EDGAR →

Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public securities-regulator filings, may be incomplete or out of date, and should be verified against the original source before you act on them.